January 21, 2016
ACTIVITY IN 2015
(Unaudiitted datta)
·CUMULATIVE ACTIVITY AS OF THE END OF DECEMBER2015
thousands of euros
2014 2015 Variation at
current
exchange
rates
Variation at
constant
exchange
rates
France 343,891 361,765 +5.2% +5.2%
Europe (excluding France) 198,918 167,714 -15.7% -11.9%
North America 52,813 63,858 +20.9% +3.8%
Other countries 14,126 14,466 +2.4% +5.7%
Group total 609,748 607,803 -0.3% -0.5%
thousands of euros
2014 2015 Variation at
current
exchange
rates
Variation at
constant
exchange
rates
Non-proprietary Homeopathic Medicines 305,501 310,555 +1.7% +0.8%
OTC Specialties 303,549 296,954 -2.2% -1.7%
Other 698 294 -57.9% -37.7%
Group total 609,748 607,803 -0.3% -0.5%
·QUARTERLY ACTIVITY IN2015 (variation at current rate)
1 st quarter 2 nd quarter 3 rd quarter 4 th quarter
thousands of euros 2014 2015 Var.
15/14
2014 2015 Var.
15/14
2014 2015 Var.
15/14
2014 2015 Var.
15/14
France 82,749 89,584 +8.3% 74,269 76,864 +3.5% 92,466 97,767 +5.7% 94,407 97,550 +3.3%
Europe (excluding France) 39,967 40,657 +1.7% 33,570 29,943 -10.8% 62,758 50,614 -19.4% 62,623 46,500 -25.7%
North America 12,662 17,193 +35.8% 10,625 12,894 +21.4% 13,109 16,055 +22.5% 16,417 17,716 +7.9%
Other countries 4,831 4,622 -4.3% 2,943 3,816 +29.7% 3,779 3,594 -4.9% 2,573 2,434 -5.4%
Group total 140,209 152,056 +8.4% 121,407 123,517 +1.7% 172,112 168,030 -2.4% 176,020 164,200 -6.7%
1 st quarter 2 nd quarter 3 rd quarter 4 th quarter
thousands of euros 2014 2015 Var.
15/14
2014 2015 Var.
15/14
2014 2015 Var.
15/14
2014 2015 Var.
15/14
Non-proprietary Homeopathic
Medicines
77,919 79,191 +1.6% 73,072 74,354 +1.8% 72,957 73,677 +1.0% 81,553 83,333 +2.2%
OTC Specialties 62,196 72,880 +17.2% 48,058 49,030 +2.0% 99,025 94,328 -4.7% 94,270 80,716 -14.4%
Other 94 -15 - 277 133 -52.0% 130 25 -80.8% 197 151 -23.4%
Group total 140,209 152,056 +8.4% 121,407 123,517 +1.7% 172,112 168,030 -2.4% 176,020 164,200 -6.7%
HIGHLIGHTS OF THE FOURTH QUARTER
Sales revenue of the fourth quarter 2015 was down by 6.7% (-6.4% at constant rate). Such decrease mainly
results from the situation in Russia.
Thus, the 2015 operating income will be lower than in 2014.
On December 22, 2015, our company has set up a new subsidiary in India and thus confirms its involvement in the
development of homeopathy in the world.
Our next update: March 16, 2016, after the close of the stock market, publication of 2015 results.
Person responsible for financial information: Christian Boiron
Contact for financial information: Véronique Bouscayrol
Investor relations: +33 (0) 4.78.45.63.43 - e-mail : boironfinances@boiron.fr
ISIN Code: FR0000061129 (BOI) - Bloomberg: BOI FP - Reuters: BOIR.PA
The group's

Boiron SA issued this content on 2016-01-21 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 2016-01-22 00:39:09 UTC

Original Document: